COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO
Catheter Precision, Inc. announced the conclusion of the patient follow-up phase for the VIVO European Registry. Data to be available Q4 2024, ongoing evaluations and studies for VIVO and LockeT -
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split
Catheter Precision, Inc. (NYSE American: VTAK) announced a 1-for-10 reverse stock split effective July 15, 2024, to ensure compliance with NYSE American requirements. No fractional shares will be issued
